³í¹®) Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-cMet Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC ¿¬¼¼¾Ïº´¿ø Æó¾Ï¼¾ÅÍ Á¶º´Ã¶ ¼¾ÅÍÀå(Á¾¾ç³»°ú ±èÇý·Ã, È«¹ÎÈñ, ÀÓ¼±¹Î, ¾Èº´Ã¶ ±³¼ö)°ú ¿¬¼¼´ë ÀÇ´ë ÀÇ»ý¸í°úÇкΠÀ±Áö¿¬ ±³¼ö